Psychiatry and Neurology, Neurology · Richmond, VA
NPI
1952513285
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
7301 Forest Ave, Suite 302
Richmond, VA, 23226
Phone (804) 288-2767
Groups this clinician bills Medicare through
Medicare paid, 2024
$288K
29,355 services
Medicare patients, 2024
804
Average age 77
Drug cost, 2024
$1.0M
3,464 prescriptions
Company payments, 2025
$8,680
From 38 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S Boyce was code J0585 (injection, onabotulinumtoxina, 1 unit), 22,560 times for 41 patients. In total Matthew S Boyce billed 29,355 services in 39 codes, and Medicare paid $288K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-01-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 22,560 | 41 | $4.96 | $112K |
| 99214 Office E&M - Established | Office | 564 | 409 | $89.17 | $50K |
| 95983 Electrical Nerve Conductivity | Office | 205 | 83 | $35.32 | $7,241 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 182 | 172 | $12.69 | $2,310 |
| 95984 Electrical Nerve Conductivity | Office | 174 | 56 | $31.55 | $5,489 |
| 99213 Office E&M - Established | Office | 152 | 121 | $65.73 | $9,991 |
| 99204 Office E&M - New | Office | 115 | 115 | $119.79 | $14K |
| 99215 Office E&M - Established | Office | 87 | 76 | $131.25 | $11K |
| 99223 Hospital E&M - Initial | Facility | 81 | 81 | $124.72 | $10K |
| 99232 Hospital E&M - Subsequent | Facility | 61 | 52 | $59.09 | $3,605 |
| 64612 Musculoskeletal | Office | 60 | 20 | $118.77 | $7,126 |
| 64616 Musculoskeletal | Office | 52 | 16 | $111.96 | $5,822 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 33 | $88.92 | $3,023 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $95.77 | $1,915 |
| 95816 Neurologic | Facility | 19 | 19 | $41.08 | $781 |
By year: 2022 $279K for 25,918 services; 2023 $286K for 28,170 services; 2024 $288K for 29,355 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Boyce prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 878 prescriptions and refills. In total Matthew S Boyce wrote 3,464 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 878 | 1,878 | 257 | $30K |
| Donepezil Hcl Generic | 291 | 593 | 90 | $3,224 |
| Primidone Generic | 239 | 515 | 71 | $7,347 |
| Rytary Carbidopa/Levodopa | 219 | 344 | 42 | $313K |
| Clonazepam Generic | 191 | 249 | 39 | $777 |
| Propranolol Hcl Er Propranolol Hcl | 188 | 409 | 60 | $8,606 |
| Amantadine Amantadine Hcl | 113 | 231 | 39 | $12K |
| Sertraline Hcl Generic | 85 | 154 | 25 | $722 |
| Quetiapine Fumarate Generic | 81 | 131 | 23 | $602 |
| Propranolol Hcl Generic | 69 | 155 | 25 | $1,217 |
| Gabapentin Generic | 64 | 116 | 23 | $874 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 58 | 126 | 16 | $838 |
| Ropinirole Hcl Generic | 53 | 85 | 11 | $1,062 |
| Midodrine Hcl Generic | 48 | 91 | 13 | $2,529 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 48 | 90 | 11 | $1,576 |
Brand drugs: - claims; generic drugs: 3,071 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S Boyce $8,680 ($8,680 in general payments such as food, travel and fees) from 38 companies. The largest payer was Abbvie Inc. with $5,855.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 30 | $5,855 |
| Teva Pharmaceuticals USA, Inc. TEVA | 37 | $304 |
| Alexion Pharmaceuticals, Inc. AZN | 10 | $263 |
| Lilly USA, LLC LLY | 8 | $244 |
| Medtronic, Inc. MDT | 2 | $216 |
| Biogen, Inc. BIIB | 10 | $213 |
| Genentech USA, Inc. ROG.SW | 5 | $144 |
| TG Therapeutics, Inc. TGTX | 5 | $110 |
| SK Life Science, Inc. | 5 | $102 |
| Janssen Biotech, Inc. JNJ | 3 | $99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.